National Donor Deferral Registry (NDDR) Helps Ensure That Deferred Donors Cannot Donate Their Plasma Again
The National Donor Deferral Registry (NDDR) is a database of permanently deferred plasma donors in North America. It is one of many voluntary, self-regulating initiatives taken by the source plasma collection industry and is an important component of the industry-driven safety measures taken to help ensure the safety of the final therapies.
All donors who test "reactive" for the following viral agents are added to the NDDR and are permanently prohibited from donating source plasma at participating licensed and industry-certified centers in the U.S. and Canada:
The NDDR first was made available to all blood and source plasma facilities in December 1993. Haemonetics, a valued partner of PPTA, is responsible for the administration and customer support services of the NDDR.
All inquires should be directed to the NDDR Customer Support Desk at 1-877-534-3578.
IQPP Standards Public Comment Period Open +
In accordance with the procedures for developing PPTA Voluntary Standards, these documents are hereby issued for public review, from October 24, 2013 – January 2, 2014. These are proposed revisions to the current IQPP Standards. The following draft documents are issued for public review:Read More
Plasma Donors and Rare Diseases Take Center Stage +Read More
Industry, Donors and Patients to Convene in Vienna +
Brussels, Belgium—The Plasma Protein Therapeutics Association (PPTA), together with Pharmig and IG Plasma are sponsoring a workshop as part of International Plasma Awareness Week, October 13-20. This event is a joint initiative of PPTA and its member companies designed to:Read More
PPTA Standards Programs